HomeCompareSRBCF vs JEPI

SRBCF vs JEPI: Dividend Comparison 2026

SRBCF yields 39215.69% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRBCF wins by $4.252735580217355e+22M in total portfolio value
10 years
SRBCF
SRBCF
● Live price
39215.69%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.252735580217355e+22M
Annual income
$42,315,093,309,418,040,000,000,000,000.00
Full SRBCF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — SRBCF vs JEPI

📍 SRBCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRBCFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRBCF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRBCF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRBCF
Annual income on $10K today (after 15% tax)
$3,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$35,967,829,313,005,333,000,000,000,000.00/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, SRBCF beats the other by $35,967,829,313,005,333,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRBCF + JEPI for your $10,000?

SRBCF: 50%JEPI: 50%
100% JEPI50/50100% SRBCF
Portfolio after 10yr
$2.1263677901086776e+22M
Annual income
$21,157,546,654,709,020,000,000,000,000.00/yr
Blended yield
99.50%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRBCF buys
0
JEPI buys
0
No recent congressional trades found for SRBCF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRBCFJEPI
Forward yield39215.69%8.40%
Annual dividend / share$2.00$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.252735580217355e+22M$29.0K
Annual income after 10y$42,315,093,309,418,040,000,000,000,000.00$1,528.62
Total dividends collected$4.251340866571809e+22M$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SRBCF vs JEPI ($10,000, DRIP)

YearSRBCF PortfolioSRBCF Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$3,932,269$3,921,568.63$11,260$840.19+$3.92MSRBCF
2$1,445,390,825$1,441,183,297.58$12,641$907.94+$1445.38MSRBCF
3$496,629,048,205$495,082,480,022.34$14,150$978.20+$496629.03MSRBCF
4$159,510,701,964,776$158,979,308,883,196.16$15,795$1,050.85+$159510701.95MSRBCF
5$47,892,225,784,148,210$47,721,549,333,045,900.00$17,584$1,125.74+$47892225784.13MSRBCF
6$13,442,027,069,357,296,000$13,390,782,387,768,257,000.00$19,526$1,202.74+$13442027069357.28MSRBCF
7$3,526,928,149,355,307,700,000$3,512,545,180,391,095,400,000.00$21,628$1,281.69+$3526928149355307.50MSRBCF
8$865,104,634,553,737,800,000,000$861,330,821,433,927,700,000,000.00$23,898$1,362.43+$865104634553737856.00MSRBCF
9$198,376,161,453,751,100,000,000,000$197,450,499,494,778,630,000,000,000.00$26,347$1,444.79+$198376161453751107584.00MSRBCF
10$42,527,355,802,173,560,000,000,000,000$42,315,093,309,418,040,000,000,000,000.00$28,982$1,528.62+$4.252735580217355e+22MSRBCF

SRBCF vs JEPI: Complete Analysis 2026

SRBCFStock

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Full SRBCF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this SRBCF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRBCF vs SCHDSRBCF vs OSRBCF vs KOSRBCF vs MAINSRBCF vs JEPQSRBCF vs XYLDSRBCF vs DIVOSRBCF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.